MedTrace Logo

Multiple Digital Biomarkers for Optimization of IBD Care

NCT07159776 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-09-08

No results posted yet for this study

Summary

To develop digital biomarkers associated with disease activity of inflammatory bowel disease

Conditions

  • Crohn Disease (CD)
  • Ulcerative Colitis (UC)
  • Inflammatory Bowel Disease (IBD)

Interventions

DEVICE

monitoring of wearable data, shopping data, biomarkers and patient reported outcomes

1. All participants will receive a wearable device type Corsano Health Cardio watch 287-2 which is provided by the sponsor via Inovigate. Participants will be encouraged to wear the device 24h per day and need to wear the wearable device at least 12 hours per day, preferential during daytime. 2. All participants will receive a loyalty card (Xtra card Colruyt group) which is provided by the sponsor via Inovigate for food data capturing. The patient is requested to execute all grocery shopping at one of the Colruyt Group stores. He/she will always need to offer the loyalty card to the cashier prior to payment. The purchase receipt will then be automatically sent to the central food data repository at the sponsor set up for this study. Non-food or non-food related data will neither be captured nor stored during the trial. 3. biomarkers in blood and feaces will be monitored according to standard of care 4. patient reported outcomes will be monitored according to standard of care

Sponsors & Collaborators

  • Agentschap Innoveren & Ondernemen (VLAIO)

    collaborator UNKNOWN

  • Imelda GI Clinical Research Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-08
Primary Completion
2026-09-30
Completion
2026-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07159776 on ClinicalTrials.gov